Biodefense, Washington, DC, USA
Event Aug 27
Molecular biology provides powerful tools for developing solutions for detection and treatment of biological agents that could be used as weapons. Commercialization of technologies in this field face unusual conditions, including the challenge of which pathogens to target, the rapid timeframe within which solutions are being sought, and ethical obstacles to clinical evaluation of preventative or therapeutic approaches. Rapid detection and identification of pathogens will be extremely important, both for monitoring and for aiding in the drug development process. Progress for vaccines or new treatments will take longer to develop, and these efforts will also rely on sensitive methods for detection of pathogens and immune response. This program is designed to provide a forum for better understanding how technologies that may contribute to biodefense are being developed and commercialized.
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018